NCT07508852
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease, +15 more
- Locations
-
- Peking university first hospital nuclear medicine Beijing, Beijing Municipality, China
Clinical trial condition
SCLC, Limited Stage
Explore clinical trials studying SCLC, Limited Stage. Study availability and eligibility vary by location and protocol.
6 public trials
6 recruiting studies
SCLC, Limited Stage trial results
NCT07309211
- Conditions
- SCLC, Limited Stage
- Locations
-
- Cancer Hospital of Shandong First Medical University Jinan, China
- Nanjing Chest Hospital Nanjing, China
- The First Affiliated Hospital with Nanjing Medical University Nanjing, China
- The affiliated hospital of qingdao university Qingdao, China
Recruiting
Omitting CTV for Primary Tumor in LS-SCLC
NCT07008716
- Conditions
- Disease Attributes, Disease Progression, Pathologic Processes, +7 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- Zhejiang Provincial Cancer Hospital Hangzhou, Zhejiang, China
Recruiting
Lung Cancer Registry
NCT04654364
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Universitätsklinik für Innere Medizin III, PMU Salzburg Salzburg, State of Salzburg, Austria
- Univ.-Klinik für Innere Medizin V, Hämatologie/Onkologie LKH-Innsbruck / Universitätskliniken Innsbruck, Tyrol, Austria
- Kepler Universitätsklinikum GmbH, Med. Campus III, Klinik für Lungenheilkunde / Pneumologie Linz, Upper Austria, Austria
NCT06911606
- Conditions
- SCLC, Limited Stage
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
Recruiting
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
NCT06371482
- Conditions
- SCLC, Limited Stage
- Locations
-
- Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China